Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 5 art units • 7 examiners • 0 of 8 (0%) have an AI response strategy ready • 28 patents granted in the last 365 days
Edgewell Personal Care Brands LLC has 9 pending office actions in Biotechnology & Pharmaceuticals. The portfolio involves 8 distinct examiners and 5 distinct art units, indicating broad examiner coverage and repeated activity within some art-unit assignments. This structure calls for a coordinated docket review that preserves matter-specific prosecution positions.
KIM, DANIELLE A is the busiest examiner, with 2 pending matters. That figure is higher than the single-matter assignment represented by the other examiner positions in the supplied profile, but it still covers only part of the pending docket. Counsel should identify any shared claim themes across the 5 art units while preparing responses for each examiner’s requirements.
The relationship between 9 actions, 8 examiners, and 5 art units suggests that examiner continuity is limited, while art-unit overlap may provide opportunities for consistent disclosure and amendment strategies. A centralized record of cited references, claim changes, and arguments can reduce inconsistency across related matters without assuming that any examiner will apply the same approach.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 3 (38%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, DANIELLE A | 2 | 36.6% | +51.9% |
| STEVENS, MARK V | 1 | 65.5% | +41.6% |
| MAEWALL, SNIGDHA | 1 | 58.8% | +10.5% |
| HOLLOMAN, NANNETTE | 1 | 60.7% | +23.1% |
| WATSON, HALEIGH NOELLE | 1 | 34.5% | +79.2% |
| BURKETT, DANIEL JOHN | 1 | 63.4% | +33.2% |
| STEINKE, SEAN JAMES | 1 | 12.5% | +42.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906797 | MINERAL SUNSCREEN COMPOSITION | STEINKE, SEAN JAMES | 132d overdue |
| 18876408 | SUNSCREEN COMPOSITION INCLUDING A SALICYLATE AND PONGAMIA PINNATA SEED EXTRACT | STEVENS, MARK V | — |
| 18737273 | PERSONAL CARE COMPOSITIONS HAVING ENHANCED ANTIOXIDANT PERFORMANCE | KIM, DANIELLE A | — |
| 18696415 | PERSONAL CARE COMPOSITION AND PERSONAL CARE PRODUCT | MAEWALL, SNIGDHA | — |
| 18552376 | WET SHAVE RAZOR CARTRIDGE HAVING BLADE SLOTS | WATSON, HALEIGH NOELLE | — |
| 18191231 | ANTI-ACNE SKIN CARE COMPOSITIONS | BURKETT, DANIEL JOHN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17906797 | MINERAL SUNSCREEN COMPOSITION | STEINKE, SEAN JAMES | 132d overdue |
| 18876408 | SUNSCREEN COMPOSITION INCLUDING A SALICYLATE AND PONGAMIA PINNATA SEED EXTRACT | STEVENS, MARK V | — |
| 18737273 | PERSONAL CARE COMPOSITIONS HAVING ENHANCED ANTIOXIDANT PERFORMANCE | KIM, DANIELLE A | — |
| 18696415 | PERSONAL CARE COMPOSITION AND PERSONAL CARE PRODUCT | MAEWALL, SNIGDHA | — |
| 18694451 | SUNSCREEN COMPOSITION WITH CRYSTALLINE ORGANIC SUNSCREEN FILTERS | KIM, DANIELLE A | — |
| 18565804 | PERSONAL CARE COMPOSITIONS AND PRODUCTS | HOLLOMAN, NANNETTE | — |
| 18552376 | WET SHAVE RAZOR CARTRIDGE HAVING BLADE SLOTS | WATSON, HALEIGH NOELLE | — |
| 18191231 | ANTI-ACNE SKIN CARE COMPOSITIONS | BURKETT, DANIEL JOHN | — |
| Art Unit | Apps |
|---|---|
| 1613 | 2 |
| 1612 | 2 |
| 3724 | 1 |
| 1624 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18876408 | SUNSCREEN COMPOSITION INCLUDING A SALICYLATE AND PONGAMIA PINNATA SEED EXTRACT | STEVENS, MARK V | — | §101§103§112 | Non-Final OA | — | Pending | Dec 18, 2024 |
| 18737273 | PERSONAL CARE COMPOSITIONS HAVING ENHANCED ANTIOXIDANT PERFORMANCE | KIM, DANIELLE A | 1613 | §103§112 | Non-Final OA | — | Pending | Jun 07, 2024 |
| 18696415 | PERSONAL CARE COMPOSITION AND PERSONAL CARE PRODUCT | MAEWALL, SNIGDHA | 1612 | §103§112 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18694451 | SUNSCREEN COMPOSITION WITH CRYSTALLINE ORGANIC SUNSCREEN FILTERS | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18565804 | PERSONAL CARE COMPOSITIONS AND PRODUCTS | HOLLOMAN, NANNETTE | 1612 | §103 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18552376 | WET SHAVE RAZOR CARTRIDGE HAVING BLADE SLOTS | WATSON, HALEIGH NOELLE | 3724 | §102§103 | Final Rejection | — | Pending | Sep 25, 2023 |
| 18191231 | ANTI-ACNE SKIN CARE COMPOSITIONS | BURKETT, DANIEL JOHN | 1624 | §103§112 | Non-Final OA | — | Pending | Mar 28, 2023 |
| 17906797 | MINERAL SUNSCREEN COMPOSITION | STEINKE, SEAN JAMES | 1619 | §103 | Non-Final OA | 132d overdue | Pending | Sep 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialEdgewell Personal Care Brands LLC has 8 pending office actions as of October 2026, spread across 5 art units and 7 examiners.
Danielle A Kim has the most, with 2 of Edgewell Personal Care Brands LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
